SIADH — SCE Medical Oncology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — SIADH — fluid restriction (750-1000 mL/day) and treat the underlying malignancy
SIADH is the most common paraneoplastic cause of hyponatraemia in SCLC (occurring in approximately 10-15% of SCLC patients). The diagnostic criteria include: euvolaemic hyponatraemia, low serum osmolality, inappropriately concentrated urine (>100 mOsm/kg), urine Na >30 mmol/L, normal thyroid and adrenal function. Initial management is fluid restriction (750-1000 mL/day). For severe/symptomatic cases, hypertonic saline (with care to avoid overcorrection — max 10 mmol/L per 24h). Demeclocycline or tolvaptan may be needed for refractory cases.
Reference: ESMO 2024 Oncological Emergencies Guidelines; NICE NG122 Lung cancer